169 related articles for article (PubMed ID: 10593699)
1. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
Moore CM; Frederick BB; Renshaw PF
J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.
Griffith HR; Stewart CC; den Hollander JA
Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715
[TBL] [Abstract][Full Text] [Related]
3. 31P RINEPT MRSI and VBM reveal alterations in brain aging associated with major depression.
Biedermann SV; Weber-Fahr W; Demirakca T; Tunc-Skarka N; Hoerst M; Henn F; Sartorius A; Ende G
Magn Reson Med; 2015 Apr; 73(4):1390-400. PubMed ID: 24798730
[TBL] [Abstract][Full Text] [Related]
4. [Application of magnetic resonance spectroscopy in the study of brain disease].
Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy in psychiatry: basic principles and applications.
Frangou S; Williams SC
Br Med Bull; 1996 Jul; 52(3):474-85. PubMed ID: 8949251
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
Lyoo IK; Renshaw PF
Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
[TBL] [Abstract][Full Text] [Related]
7. Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine
Lyros E; Ragoschke-Schumm A; Kostopoulos P; Sehr A; Backens M; Kalampokini S; Decker Y; Lesmeister M; Liu Y; Reith W; Fassbender K
Neurobiol Aging; 2020 Mar; 87():60-69. PubMed ID: 31902521
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise.
Keshavan MS; Kapur S; Pettegrew JW
Am J Psychiatry; 1991 Aug; 148(8):976-85. PubMed ID: 1853987
[TBL] [Abstract][Full Text] [Related]
10. Neuroanatomic substrates of late-life mental disorders.
Narayan M; Bremner JD; Kumar A
J Geriatr Psychiatry Neurol; 1999; 12(3):95-106. PubMed ID: 10593698
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
13. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
Dager SR; Steen RG
Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
[TBL] [Abstract][Full Text] [Related]
14. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
Mato Abad V; Quirós A; García-Álvarez R; Loureiro JP; Alvarez-Linera J; Frank A; Hernández-Tamames JA
J Alzheimers Dis; 2014; 42(3):801-11. PubMed ID: 24927708
[TBL] [Abstract][Full Text] [Related]
15. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
Port JD
Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
[TBL] [Abstract][Full Text] [Related]
17. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.
Dager SR; Corrigan NM; Richards TL; Posse S
Top Magn Reson Imaging; 2008 Apr; 19(2):81-96. PubMed ID: 19363431
[TBL] [Abstract][Full Text] [Related]
18. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy in neonatal hypoxic-ischaemic insults.
Cady EB
Childs Nerv Syst; 2001 Feb; 17(3):145-9. PubMed ID: 11305767
[TBL] [Abstract][Full Text] [Related]
20. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
